Global Neurogenetic Testing Market Growth (Status and Outlook) 2022-2028
- LP 4947500
- 86 Pages
- April 2022
- Medical Devices
The United States Neurogenetic Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Neurogenetic Testing market, reaching US$ million by the year 2028. As for the Europe Neurogenetic Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Neurogenetic Testing players cover Labcorp, Pacific Biosciences of California, Victorian Clinical Genetics Services, and MedGenome Labs, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurogenetic Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
MRI
Next Generation Sequencing
Multiplex Ligation-dependent Probe Amplification (MLPA)
Fragment Analysis PCR
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Specialty Clinics
Research Institutes
Diagnostics Laboratories
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Labcorp
Pacific Biosciences of California
Victorian Clinical Genetics Services
MedGenome Labs
Blueprint Genetics
GeneDx
Mayo Clinic
Neurogene
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Neurogenetic Testing Market Size 2017-2028
2.1.2 Neurogenetic Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Neurogenetic Testing Segment by Type
2.2.1 MRI
2.2.2 Next Generation Sequencing
2.2.3 Multiplex Ligation-dependent Probe Amplification (MLPA)
2.2.4 Fragment Analysis PCR
2.3 Neurogenetic Testing Market Size by Type
2.3.1 Neurogenetic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Neurogenetic Testing Market Size Market Share by Type (2017-2022)
2.4 Neurogenetic Testing Segment by Application
2.4.1 Hospitals
2.4.2 Specialty Clinics
2.4.3 Research Institutes
2.4.4 Diagnostics Laboratories
2.5 Neurogenetic Testing Market Size by Application
2.5.1 Neurogenetic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Neurogenetic Testing Market Size Market Share by Application (2017-2022)
3 Neurogenetic Testing Market Size by Player
3.1 Neurogenetic Testing Market Size Market Share by Players
3.1.1 Global Neurogenetic Testing Revenue by Players (2020-2022)
3.1.2 Global Neurogenetic Testing Revenue Market Share by Players (2020-2022)
3.2 Global Neurogenetic Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Neurogenetic Testing by Regions
4.1 Neurogenetic Testing Market Size by Regions (2017-2022)
4.2 Americas Neurogenetic Testing Market Size Growth (2017-2022)
4.3 APAC Neurogenetic Testing Market Size Growth (2017-2022)
4.4 Europe Neurogenetic Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Neurogenetic Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Neurogenetic Testing Market Size by Country (2017-2022)
5.2 Americas Neurogenetic Testing Market Size by Type (2017-2022)
5.3 Americas Neurogenetic Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurogenetic Testing Market Size by Region (2017-2022)
6.2 APAC Neurogenetic Testing Market Size by Type (2017-2022)
6.3 APAC Neurogenetic Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Neurogenetic Testing by Country (2017-2022)
7.2 Europe Neurogenetic Testing Market Size by Type (2017-2022)
7.3 Europe Neurogenetic Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Neurogenetic Testing by Region (2017-2022)
8.2 Middle East & Africa Neurogenetic Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Neurogenetic Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Neurogenetic Testing Market Forecast
10.1 Global Neurogenetic Testing Forecast by Regions (2023-2028)
10.1.1 Global Neurogenetic Testing Forecast by Regions (2023-2028)
10.1.2 Americas Neurogenetic Testing Forecast
10.1.3 APAC Neurogenetic Testing Forecast
10.1.4 Europe Neurogenetic Testing Forecast
10.1.5 Middle East & Africa Neurogenetic Testing Forecast
10.2 Americas Neurogenetic Testing Forecast by Country (2023-2028)
10.2.1 United States Neurogenetic Testing Market Forecast
10.2.2 Canada Neurogenetic Testing Market Forecast
10.2.3 Mexico Neurogenetic Testing Market Forecast
10.2.4 Brazil Neurogenetic Testing Market Forecast
10.3 APAC Neurogenetic Testing Forecast by Region (2023-2028)
10.3.1 China Neurogenetic Testing Market Forecast
10.3.2 Japan Neurogenetic Testing Market Forecast
10.3.3 Korea Neurogenetic Testing Market Forecast
10.3.4 Southeast Asia Neurogenetic Testing Market Forecast
10.3.5 India Neurogenetic Testing Market Forecast
10.3.6 Australia Neurogenetic Testing Market Forecast
10.4 Europe Neurogenetic Testing Forecast by Country (2023-2028)
10.4.1 Germany Neurogenetic Testing Market Forecast
10.4.2 France Neurogenetic Testing Market Forecast
10.4.3 UK Neurogenetic Testing Market Forecast
10.4.4 Italy Neurogenetic Testing Market Forecast
10.4.5 Russia Neurogenetic Testing Market Forecast
10.5 Middle East & Africa Neurogenetic Testing Forecast by Region (2023-2028)
10.5.1 Egypt Neurogenetic Testing Market Forecast
10.5.2 South Africa Neurogenetic Testing Market Forecast
10.5.3 Israel Neurogenetic Testing Market Forecast
10.5.4 Turkey Neurogenetic Testing Market Forecast
10.5.5 GCC Countries Neurogenetic Testing Market Forecast
10.6 Global Neurogenetic Testing Forecast by Type (2023-2028)
10.7 Global Neurogenetic Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Labcorp
11.1.1 Labcorp Company Information
11.1.2 Labcorp Neurogenetic Testing Product Offered
11.1.3 Labcorp Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Labcorp Main Business Overview
11.1.5 Labcorp Latest Developments
11.2 Pacific Biosciences of California
11.2.1 Pacific Biosciences of California Company Information
11.2.2 Pacific Biosciences of California Neurogenetic Testing Product Offered
11.2.3 Pacific Biosciences of California Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Pacific Biosciences of California Main Business Overview
11.2.5 Pacific Biosciences of California Latest Developments
11.3 Victorian Clinical Genetics Services
11.3.1 Victorian Clinical Genetics Services Company Information
11.3.2 Victorian Clinical Genetics Services Neurogenetic Testing Product Offered
11.3.3 Victorian Clinical Genetics Services Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Victorian Clinical Genetics Services Main Business Overview
11.3.5 Victorian Clinical Genetics Services Latest Developments
11.4 MedGenome Labs
11.4.1 MedGenome Labs Company Information
11.4.2 MedGenome Labs Neurogenetic Testing Product Offered
11.4.3 MedGenome Labs Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 MedGenome Labs Main Business Overview
11.4.5 MedGenome Labs Latest Developments
11.5 Blueprint Genetics
11.5.1 Blueprint Genetics Company Information
11.5.2 Blueprint Genetics Neurogenetic Testing Product Offered
11.5.3 Blueprint Genetics Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Blueprint Genetics Main Business Overview
11.5.5 Blueprint Genetics Latest Developments
11.6 GeneDx
11.6.1 GeneDx Company Information
11.6.2 GeneDx Neurogenetic Testing Product Offered
11.6.3 GeneDx Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 GeneDx Main Business Overview
11.6.5 GeneDx Latest Developments
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Information
11.7.2 Mayo Clinic Neurogenetic Testing Product Offered
11.7.3 Mayo Clinic Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Mayo Clinic Main Business Overview
11.7.5 Mayo Clinic Latest Developments
11.8 Neurogene
11.8.1 Neurogene Company Information
11.8.2 Neurogene Neurogenetic Testing Product Offered
11.8.3 Neurogene Neurogenetic Testing Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Neurogene Main Business Overview
11.8.5 Neurogene Latest Developments
12 Research Findings and Conclusion
Table 1. Neurogenetic Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of MRI
Table 3. Major Players of Next Generation Sequencing
Table 4. Major Players of Multiplex Ligation-dependent Probe Amplification (MLPA)
Table 5. Major Players of Fragment Analysis PCR
Table 6. Neurogenetic Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Neurogenetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Neurogenetic Testing Market Size Market Share by Type (2017-2022)
Table 9. Neurogenetic Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Neurogenetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Neurogenetic Testing Market Size Market Share by Application (2017-2022)
Table 12. Global Neurogenetic Testing Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Neurogenetic Testing Revenue Market Share by Player (2020-2022)
Table 14. Neurogenetic Testing Key Players Head office and Products Offered
Table 15. Neurogenetic Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Neurogenetic Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Neurogenetic Testing Market Size Market Share by Regions (2017-2022)
Table 20. Americas Neurogenetic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Neurogenetic Testing Market Size Market Share by Country (2017-2022)
Table 22. Americas Neurogenetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Neurogenetic Testing Market Size Market Share by Type (2017-2022)
Table 24. Americas Neurogenetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Neurogenetic Testing Market Size Market Share by Application (2017-2022)
Table 26. APAC Neurogenetic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Neurogenetic Testing Market Size Market Share by Region (2017-2022)
Table 28. APAC Neurogenetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Neurogenetic Testing Market Size Market Share by Type (2017-2022)
Table 30. APAC Neurogenetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Neurogenetic Testing Market Size Market Share by Application (2017-2022)
Table 32. Europe Neurogenetic Testing Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Neurogenetic Testing Market Size Market Share by Country (2017-2022)
Table 34. Europe Neurogenetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Neurogenetic Testing Market Size Market Share by Type (2017-2022)
Table 36. Europe Neurogenetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Neurogenetic Testing Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Neurogenetic Testing Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Neurogenetic Testing Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Neurogenetic Testing Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Neurogenetic Testing Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Neurogenetic Testing Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Neurogenetic Testing Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Neurogenetic Testing
Table 45. Key Market Challenges & Risks of Neurogenetic Testing
Table 46. Key Industry Trends of Neurogenetic Testing
Table 47. Global Neurogenetic Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Neurogenetic Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Neurogenetic Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Neurogenetic Testing Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Neurogenetic Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Neurogenetic Testing Market Size Market Share Forecast by Application (2023-2028)
Table 53. Labcorp Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 54. Labcorp Neurogenetic Testing Product Offered
Table 55. Labcorp Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Labcorp Main Business
Table 57. Labcorp Latest Developments
Table 58. Pacific Biosciences of California Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 59. Pacific Biosciences of California Neurogenetic Testing Product Offered
Table 60. Pacific Biosciences of California Main Business
Table 61. Pacific Biosciences of California Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Pacific Biosciences of California Latest Developments
Table 63. Victorian Clinical Genetics Services Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 64. Victorian Clinical Genetics Services Neurogenetic Testing Product Offered
Table 65. Victorian Clinical Genetics Services Main Business
Table 66. Victorian Clinical Genetics Services Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Victorian Clinical Genetics Services Latest Developments
Table 68. MedGenome Labs Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 69. MedGenome Labs Neurogenetic Testing Product Offered
Table 70. MedGenome Labs Main Business
Table 71. MedGenome Labs Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. MedGenome Labs Latest Developments
Table 73. Blueprint Genetics Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 74. Blueprint Genetics Neurogenetic Testing Product Offered
Table 75. Blueprint Genetics Main Business
Table 76. Blueprint Genetics Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Blueprint Genetics Latest Developments
Table 78. GeneDx Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 79. GeneDx Neurogenetic Testing Product Offered
Table 80. GeneDx Main Business
Table 81. GeneDx Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. GeneDx Latest Developments
Table 83. Mayo Clinic Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 84. Mayo Clinic Neurogenetic Testing Product Offered
Table 85. Mayo Clinic Main Business
Table 86. Mayo Clinic Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Mayo Clinic Latest Developments
Table 88. Neurogene Details, Company Type, Neurogenetic Testing Area Served and Its Competitors
Table 89. Neurogene Neurogenetic Testing Product Offered
Table 90. Neurogene Main Business
Table 91. Neurogene Neurogenetic Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Neurogene Latest Developments
List of Figures
Figure 1. Neurogenetic Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Neurogenetic Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Neurogenetic Testing Market Size Market Share by Type in 2021
Figure 7. Neurogenetic Testing in Hospitals
Figure 8. Global Neurogenetic Testing Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Neurogenetic Testing in Specialty Clinics
Figure 10. Global Neurogenetic Testing Market: Specialty Clinics (2017-2022) & ($ Millions)
Figure 11. Neurogenetic Testing in Research Institutes
Figure 12. Global Neurogenetic Testing Market: Research Institutes (2017-2022) & ($ Millions)
Figure 13. Neurogenetic Testing in Diagnostics Laboratories
Figure 14. Global Neurogenetic Testing Market: Diagnostics Laboratories (2017-2022) & ($ Millions)
Figure 15. Global Neurogenetic Testing Market Size Market Share by Application in 2021
Figure 16. Global Neurogenetic Testing Revenue Market Share by Player in 2021
Figure 17. Global Neurogenetic Testing Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Neurogenetic Testing Market Size 2017-2022 ($ Millions)
Figure 19. APAC Neurogenetic Testing Market Size 2017-2022 ($ Millions)
Figure 20. Europe Neurogenetic Testing Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Neurogenetic Testing Market Size 2017-2022 ($ Millions)
Figure 22. Americas Neurogenetic Testing Value Market Share by Country in 2021
Figure 23. Americas Neurogenetic Testing Consumption Market Share by Type in 2021
Figure 24. Americas Neurogenetic Testing Market Size Market Share by Application in 2021
Figure 25. United States Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Neurogenetic Testing Market Size Market Share by Region in 2021
Figure 30. APAC Neurogenetic Testing Market Size Market Share by Application in 2021
Figure 31. China Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Neurogenetic Testing Market Size Market Share by Country in 2021
Figure 38. Europe Neurogenetic Testing Market Size Market Share by Type in 2021
Figure 39. Europe Neurogenetic Testing Market Size Market Share by Application in 2021
Figure 40. Germany Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Neurogenetic Testing Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Neurogenetic Testing Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Neurogenetic Testing Market Size Market Share by Application in 2021
Figure 48. Egypt Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Neurogenetic Testing Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 54. APAC Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 55. Europe Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 57. United States Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 58. Canada Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 61. China Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 62. Japan Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 63. Korea Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 65. India Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 66. Australia Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 67. Germany Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 68. France Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 69. UK Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 70. Italy Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 71. Russia Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 72. Spain Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 75. Israel Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Neurogenetic Testing Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
